Full Text:
<2460>
Summary: 
<2026>
CLC number: R511
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2020-05-09
Cited: 0
Clicked: 4686
Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report
| ||||||||||||||
Tian-ming Xuan, Xing-xiang Wang, Xiang-yuan Pu, Wei-li Han, Xiao-gang Guo. Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report[J]. Journal of Zhejiang University Science B, 2020, 21(5): 411-415.
@article{title="Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report",
author="Tian-ming Xuan, Xing-xiang Wang, Xiang-yuan Pu, Wei-li Han, Xiao-gang Guo",
journal="Journal of Zhejiang University Science B",
volume="21",
number="5",
pages="411-415",
year="2020",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2000182"
}
%0 Journal Article
%T Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report
%A Tian-ming Xuan
%A Xing-xiang Wang
%A Xiang-yuan Pu
%A Wei-li Han
%A Xiao-gang Guo
%J Journal of Zhejiang University SCIENCE B
%V 21
%N 5
%P 411-415
%@ 1673-1581
%D 2020
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2000182
TY - JOUR
T1 - Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report
A1 - Tian-ming Xuan
A1 - Xing-xiang Wang
A1 - Xiang-yuan Pu
A1 - Wei-li Han
A1 - Xiao-gang Guo
J0 - Journal of Zhejiang University Science B
VL - 21
IS - 5
SP - 411
EP - 415
%@ 1673-1581
Y1 - 2020
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2000182
Abstract: We present an unusual case of a patient with bilateral-lung Transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI).
[1]Chen NS, Zhou M, Dong X, et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223):507-513.
[2]Han YL, Zeng HS, Jiang H, et al., 2020. CSC expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID-19 epidemic. Circulation, in press.
[3]Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506.
[4]Peiris JSM, Chu CM, Cheng VCC, et al., 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 361(9371):1767-1772.
[5]Thygesen K, Alpert JS, Jaffe AS, et al., 2018. Fourth universal definition of myocardial infarction (2018). J Am College Cardiol, 72(18):2231-2264.
[6]Tsui KL, Leung TC, Yam LYC, et al., 2005. Coronary plague instability in severe acute respiratory syndrome. Int J Cardiol, 99(3):471-472.
[7]Wang DW, Hu B, Hu C, et al., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11):1061-1069.
[8]Wuhan Municipal Health Commission, 2020. Website of Wuhan Municipal Health Commission, Hubei, China. http://wjw.wuhan.gov.cn/front/web/showDetail/2020011609057 [Accessed on Mar. 26, 2020] (in Chinese).
ORCID: 
Open peer comments: Debate/Discuss/Question/Opinion
<1>